Lipomatosis benign symmetric (overview) E88.8

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 16.05.2024

Dieser Artikel auf Deutsch

Synonym(s)

Adenolipomatosis symmetrical; Adiposis symmetrica; Bensaude syndrome; Buffalo Stools; circumscribed symmetrical lipomatosis; diffuse symmetrical lipomatosis; diffuse symmetrical with preference for the neck area (Madelung-Fetthals); generalized symmetrical lipomatosis; Launois-Bensaude syndrome; Lipomatosis; Lipomatosis defined symmetrical; Lipomatosis diffuse symmetrical; Lipomatosis diffuse symmetrical with preference of the neck area (Madelung-Fetthals); Lipomatosis generalized symmetrical; Lipomatosis multiple symmetrical; Lipomatosis simplex indolens; Madelung disease; Madelung`s disease; multiple symmetrical lipomatosis; Symmetrical adenolipomatosis

History
This section has been translated automatically.

Launois and Bensaude, 1898

Definition
This section has been translated automatically.

Benign disease characterized by disproportionate, unencapsulated, diffuse subcutaneous fatty tissue hyperplasia (especially in the area of the upper trunk), which leads to a different (e.g. pseudoathletic) habitus depending on its location.

Classification
This section has been translated automatically.

Classification using the distribution pattern (according to Donhauser):

Etiopathogenesis
This section has been translated automatically.

Discussed are latent familial clustering, associations with metabolic disorders(hyperlipoproteinemia type IV, hyperuricemia, diabetes mellitus, hypothyroidism and alcoholism with liver dysfunction) and autonomous growth of fat cells due to resistance to catecholamines.

Manifestation
This section has been translated automatically.

Occurs mainly in men with alcohol abuse. Men are about 13 times more frequently affected than women. Age: 30-60 years.

Localization
This section has been translated automatically.

Neck ( Madelung-Fetthals), above all neck (buffalo humps), upper arm range (puff sleeve lipomatose), lateral trunk portion, occasionally thigh bending sides.

Clinical features
This section has been translated automatically.

Diffuse symmetric, massive, tumor-like, doughy dermal proliferation of fatty tissue. Differentiation of lipomas is difficult because of the lack of encapsulation.

In the pseudoatheltic type, there is diffuse fat proliferation on the upper arms as well as in the shoulder area, resulting in a pseudoathletic habitus due to broad-shoulderedness.

In gynecoid type III, the fat deposits are predominantly found on the abdomen and in the pelvic girdle area.

A rare localized variant manifests exclusively on the soles of the feet. Rapid (within 1-2 years), relapsing development followed by stationary adipose tissue hyperplasia with no spontaneous tendency to regress or degenerate.

In Madelung-Fetthals (type I), mechanical limitation of movement of upper cervical joints, dyspnea due to laryngeal and tracheal compression; planar erythema with telangiectasias of the arms (and legs), livedo reticularis.

Frequent association with internal diseases, esp. polyneuropathy, chronic liver damage, gynecomastia, testicular atrophy, diabetes mellitus, hyperlipidemia, hyperuricemia, lung carcinoma, Kaposi's sarcoma, myalgias, arthralgias, and varicosis.

Histology
This section has been translated automatically.

Diffuse, non-separated proliferation of mature univacuolar lipocytes with tongue-shaped extensions into adjacent structures.

Complication(s)
This section has been translated automatically.

Associated metabolic disorders: alcoholic hepatopathy (60-90% of patients), hyperuricemia as well as manifest gout, diabetes mellitus, hyperlipidemia; often hypertension. Syntropia with oro-pharyngeal carcinomas and carcinomas of the upper respiratory tract and varicosis of the leg veins.

Therapy
This section has been translated automatically.

No causal therapy known. Patients often have frustrated dietary attempts behind them. Due to the autonomy of the fat masses, diet or tumor cachexia shows little effect on the affected areas.

Surgical reduction (especially when compressing important structures) or liposuction are possible in principle, but are followed by a high recurrence rate (informing the patient!). In some patients success with salbutamol (e.g. Salbutamol Atid 8 retard) 16 mg/day is reported.

The treatment of associated diseases, e.g. alcoholism, usually does not change the fatty tissue hyperplasia.

Operative therapie
This section has been translated automatically.

By means of liposuction a lasting reduction of fatty tissue can be achieved. The procedure is complex and requires numerous sessions to achieve an acceptable effect.

Progression/forecast
This section has been translated automatically.

Standstill of the disease with absolute abstinence from alcohol is possible. Explosive deterioration after trauma or surgical fat tissue reduction (rhytidectomy, liposuction) has been observed. Adipose tissue hyperplasia cannot be influenced dietetically. Resistance in tumor cachexia.

Literature
This section has been translated automatically.

  1. Amon U et al (1995) Abdominal variant of a benign symmetrical lipomatosis Launois-Bensaude. dermatologist 46: 722-725
  2. Beikert F et al (2015) Liposuction for benign symmetrical lkpomatosis Lenois-Bensaude type II. Act Dermatol 41: 381
  3. Carlin MC et al (1988) Multiple symmetric lipomatosis: treatment with liposuction. Jam Acad Dermatol 18: 359-362
  4. Constantinidis J et al (2003) Surgical therapy of Madelung's disease in the head and neck area. HNO 51: 216-220
  5. Donhauser G et al (1991) Benign symmetrical lipomatosis Launois-Bensaude type 3 and Bureau-Barrière syndrome. dermatologist 42: 311-314
  6. Donhauser et al (1991) Benign symmetrical lipomatosis Launois-Bensaude type III and Bureau-Barrière syndrome. dermatologist 42: 311-314
  7. Launois PE, Bensaude R (1898) De l'adénolipomatose symétrique. Bull Soc Méd Hôp Paris, Mémoires 1: 298-318
  8. Lee HW et al (2003) Multiple symmetric lipomatosis: Korean experience. Dermatol Surgery 29: 235-240
  9. Leung NWY et al (1987) Multiple symmetric lipomatosis (Launois-Bensaude syndrome): effect of oral salbutamol. Clin Endocrinol 7: 601-606
  10. Madelung OW (1888) About the fat neck (diffuse lipoma of the neck). Langenbecks Arch Klin Surgeon 37: 106-130
  11. Nisoli E et al (2002) Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells. J Pathol 198: 378-387
  12. Novak N et al (2000) Benign symmetrical Launois-Bensaude type II lipomatosis with market systemic involvement and psoriasis. dermatologist 51: 427-430

Disclaimer

Please ask your physician for a reliable diagnosis. This website is only meant as a reference.

Authors

Last updated on: 16.05.2024